Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

NCT00319787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Prostate Cancer

Interventions

DRUG: Iressa

Sponsor

AstraZeneca